01 1Alembic Pharmaceuticals Limited
01 1CANAGLIFLOZIN
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2017-01-24
Pay. Date : 2016-11-29
DMF Number : 31161
Submission : 2016-12-02
Status : Active
Type : II
20
Alembic Pharmaceuticals Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is CANAGLIFLOZIN, with a corresponding US DMF Number 31161.
Remarkably, this DMF maintains an Active status since its submission on December 02, 2016, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 24, 2017, and payment made on November 29, 2016, indicating their dedication to facilitating drug approvals, Categorized as Type II
